About 10 results found for searched term "Vancomycin" (0.134 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M4862 | Vancomycin HCl | Antibiotic |
| Vancocin HCl | ||
| Vancomycin HCl is a hydrochloride of vancomycin that is a narrow-spectrum glycopeptide antibacterial agent. | ||
| M9334 | Vancomycin | Animal Modeling |
| Vancomycin is a glycopeptide antibiotic as well as a macrocyclic compound that can be used to construct models of bronchiectasis combined with lung infections, as well as for studies related to various bacterial infectious conditions. | ||
| M55546 | Vancomycin-d10 2TFA salt | Animal Modeling |
| Vancomycin-d10 2TFA salt | ||
| M6129 | Dalfopristin | Antibiotic |
| RP54476 | ||
| Dalfopristin is a semi-synthetic antibiotic. , Quinupristin/Dalfopristin (Q/D) is a valuable alternative antibiotic Vancomycin, with multidrug resistance of Enterococcus faecium infection research. | ||
| M6131 | Pristinamycin | Anti-infection |
| Pristinamycine | ||
| Pristinamycin, produced by Streptomyces pristinaespiralis, is an orally active streptogramin-like antibiotic. The pristinamycins exhibit a strong synergistic antibacterial activity against a wide range of Gram-positive and some Gram-negative bacteria, including methicillin- and vancomycin-resistant strains. | ||
| M10881 | Ristocetin | Antibiotic |
| Ristomycin | ||
| Ristocetin is a peptide antibiotic that acts on the bacterial cell wall and inhibits the synthesis of the cell wall. The antimicrobial spectrum of risethibin is similar to that of vancomycin. Ristocetin has significant antibacterial activity against gram-positive bacteria, and has strong activity against hemolytic streptococcus, pneumococcus, Staphylococcus vanidavia, aerogenes and tetanus bacillus. | ||
| M24753 | Suvratoxumab | Anti-infection |
| MEDI4893 | ||
| Suvratoxumab (MEDI4893) is a long-acting, high-affinity humanized anti-α-toxin monoclonal antibody (IgG1κ type). Suvratoxumab potently neutralizes α-toxin, a key S. aureus virulence factor. Suvratoxumab improves survival and reduces lung injury in an immunocompromised mice model of pneumonia. Suvratoxumab also enhances the antibacterial activity of Vancomycin or Linezolid . | ||
| M29688 | Ceftobiprole medocaril sodium | Antibiotic |
| BAL5788 sodium | ||
| Ceftobiprole medocaril (BAL5788) sodium is the parenteral proagent of Ceftobiprole. Ceftobiprole is a parenteral pyrrolidinone cephalosporin. Ceftobiprole is a broad-spectrum cephalosporin with high levels of in vitro activity against methicillin- (MRSA) and vancomycin-resistant staphylococci (VRSA) and penicillin-resistant streptococci. Ceftobiprole also inhibits gram-positive and gram-negative pathogens. | ||
| M30013 | Ceftobiprole medocaril | Antibiotic |
| BAL5788 | ||
| Ceftobiprole medocaril (BAL5788) is the parenteral proagent of Ceftobiprole. Ceftobiprole is a parenteral pyrrolidinone cephalosporin. Ceftobiprole is a broad-spectrum cephalosporin with high levels of in vitro activity against methicillin- (MRSA) and vancomycin-resistant staphylococci (VRSA) and penicillin-resistant streptococci. Ceftobiprole also inhibits gram-positive and gram-negative pathogens. | ||
| M40503 | Lugdunin | Anti-infection |
| Lugdunin is a class of non-ribosomal peptides (NRPs) with good antimicrobial activity and inhibits methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE) and Listeria monocytogenes. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
